Inotropic Versus Chronotropic, Dromotropic, and Coronary Vasodilator Actions of DPI 201–106, a Novel Positive Inotropic Agent, in the Dog Heart
- 1 April 1987
- journal article
- research article
- Published by Wolters Kluwer Health in Journal of Cardiovascular Pharmacology
- Vol. 9 (4) , 451-460
- https://doi.org/10.1097/00005344-198704000-00010
Abstract
Inotropic versus chronotropic, dromotropic, and vascular effects of DPI 201-106 were assessed in isolated, blood-perfused papillary muscle, sinoatrial (SA) node, and atrioventricular (AV) node preparations of dogs. DPI 201-1-6 was administered intraarterially. In paced papillary muscles the drug produced an increase in developed tension. In spontaneously beating papillary muscles the drug slightly decreased the beating rate. In SA node preparations the drug decreased sinus rate, and atrial standstill ensued from the highest dose. In AV node preparations the drug affected AV conduction only when administered not the node artery, and in high dose second- or third-degree AV block occurred. In all preparations the drug increased blood flow. DPI 201-106 at the dosage that produced a 50% increase in the force of contraction of ventricular muscle increased coronary blood flow by 8.4%, AV conduction time by 7.6%, and decreased sinus rate by 2.6%, indicating its high selectivity for force. When infused into the AV node artery, the drug in high doses produced dose-dependent prolongations of both the AV nodal conduction time and the functional refractory period of the AV node, which were pronounced with elevation of the pacing rate. These effects of DPI 201-106 are very similar to those of calcium channel blockers.This publication has 13 references indexed in Scilit:
- DPI 201-106, a novel cardioactive agent. Combination of cAMP-independent positive inotropic, negative chronotropic, action potential prolonging and coronary dilatory propertiesNaunyn-Schmiedebergs Archiv für experimentelle Pathologie und Pharmakologie, 1985
- Separation of the Coronary Vasodilator from the Cardiac Effects of PN 200–110, a New Dihydropyridine Calcium Antagonist, in the Dog HeartJournal of Cardiovascular Pharmacology, 1985
- Coronary Vasodilator Compared to Cardiac Effects of PY 108–068, a New Dihydropyridine Vasodilator, on Isolated, Blood-Perfused Dog-Heart PreparationsJournal of Cardiovascular Pharmacology, 1984
- Comparison of the cardiovascular and biochemical profiles of a new positive inotropic drug, AR-L 115 BS, with those of theophylline.Japanese Heart Journal, 1984
- Comparative effects of three calcium antagonists, diltiazem, verapamil and nifedipine, on the sinoatrial and atrioventricular nodes. Experimental and clinical studies.Circulation, 1981
- Effect of tetrodotoxin on action potentials of the conducting system in the dog heartAmerican Journal of Physiology-Heart and Circulatory Physiology, 1979
- EFFECT OF AMILORIDE ON ISOLATED GUINEA-PIG ATRIUM1979
- Effects on Atrio-Ventricular Conduction of Propranolol, Pindolol and Carteolol in the Dog Heart in Situ as Assessed by Automated DevicesThe Japanese Journal of Pharmacology, 1978
- STUDIES ON VERATRUM ALKALOIDS .16. THE ACTION OF EPINEPHRINE AND OF VERATRAMINE ON THE FUNCTIONAL REFRACTORY PERIOD OF THE AURICULO-VENTRICULAR TRANSMISSION IN THE HEART-LUNG PREPARATION OF THE DOG1951
- A SIMPLIFIED METHOD OF EVALUATING DOSE-EFFECT EXPERIMENTS1949